Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.160
+0.060 (5.45%)
Dec 20, 2024, 4:00 PM EST - Market closed
Estrella Immunopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '24 Dec 20, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Market Capitalization | 42 | 38 | 19 | - | - |
| Market Cap Growth | 156.70% | 101.23% | - | - | - |
| Enterprise Value | 40 | 33 | 21 | - | - |
| Last Close Price | 1.16 | 1.05 | 10.84 | 10.00 | - |
| PB Ratio | 56.24 | 8.94 | -2.82 | - | - |
| P/TBV Ratio | 56.25 | 8.94 | - | - | - |
| Debt / Equity Ratio | 0.01 | 0.00 | 0.00 | - | - |
| Quick Ratio | 0.60 | 23.05 | 0.25 | 4.32 | - |
| Current Ratio | 0.75 | 24.65 | 0.28 | 5.20 | - |
| Return on Assets (ROA) | -35.45% | -122.12% | -174.75% | - | - |
| Earnings Yield | -21.01% | -19.14% | -58.56% | - | - |
| FCF Yield | -42.92% | -42.07% | -7.04% | - | - |
| Buyback Yield / Dilution | -6450.97% | -8764.81% | - | - | - |
| Total Shareholder Return | -6450.97% | -8764.81% | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.